pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Preclinical
FMC-220
Solid Tumor
LG Chem Ltd
Phase 1
FMT-XBI-302
Graft Versus Host Disease (GVHD)
Shenzhen UnknownBio Biotechnology Co Ltd
Preclinical
FN-2012
Idiopathic Pulmonary Fibrosis
Faknostics LLC
FOAMING HAND WASH
← prev
page 96 of 271
next →
Pain
89
Neurology
1
FOAMING HAND WASH (CHLORHEXIDINE GLUCONATE)
no indication
XTTRIUM
FOCALIN XR
FOCALIN XR (DEXMETHYLPHENIDATE HYDROCHLORIDE)
no indication
Sandoz Inc
FOLLISTIM AQ
FOLLISTIM AQ (FOLLITROPIN ALFA/BETA)
no indication
Organon USA LLC
Preclinical
FORCEM-23D
Duchenne Muscular Dystrophy
$DYN
Dyne Therapeutics, Inc.
Phase 1
FORX-428
Metastatic Breast Cancer
FoRx Therapeutics AG
FORZINITY
FORZINITY (ELAMIPRETIDE HYDROCHLORIDE)
no indication
Stealth BioTherapeutics Inc
FOSAMAX
FOSAMAX (ALENDRONATE SODIUM)
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination o…
$OGN
Organon & Co.
FOSAMAX PLUS D
FOSAMAX PLUS D (ALENDRONATE SODIUM)
1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination o…
$OGN
Organon & Co.
FOSAPREPITANT
FOSAPREPITANT
no indication
DR REDDYS
FOSTER AND THRIVE ALLERGY AND CONGESTION D
FOSTER AND THRIVE ALLERGY AND CONGESTION D (FEXOFENADINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE)
no indication
L PERRIGO CO
FOUNDAYO
FOUNDAYO (ORFORGLIPRON CALCIUM)
1 INDICATIONS AND USAGE FOUNDAYO TM is indicated in combi…
$LLY
ELI LILLY & Co
Preclinical
FP-016
Unspecified Neurologic Disorders
Foresee Pharmaceuticals Co Ltd
Preclinical
FP-017
Unspecified Neurologic Disorders
Foresee Pharmaceuticals Co Ltd
Preclinical
FP-0210
no indication
Formosa Pharmaceuticals Inc
Phase 2
FP-101
Vasomotor Symptoms of Menopause (Hot Flashes)
Fervent Pharmaceuticals LLC
Phase 1
FPI-2068
Metastatic Colorectal Cancer
Fusion Pharmaceuticals Inc
Phase 2
FPI-2265
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Fusion Pharmaceuticals Inc
Phase 1
FS-120
Advanced Malignancy
invoX Pharma Ltd
Preclinical
FT-002a-O
Castration-Resistant Prostate Cancer (CRPC)
AecorBio Inc
Phase 1
FT-522
B-Cell Non-Hodgkin Lymphoma
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-576
Refractory Multiple Myeloma
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-819
Idiopathic Inflammatory Myopathy (IIM)
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-825
Colorectal Cancer
$FATE
FATE THERAPEUTICS INC
Phase 1
FT-836
Breast Cancer
$FATE
FATE THERAPEUTICS INC
Preclinical
FT-839
Hematological Tumor
$FATE
FATE THERAPEUTICS INC
Preclinical
FT-8XX
Unspecified Cancer
$FATE
FATE THERAPEUTICS INC
FULPHILA
FULPHILA (PEGFILGRASTIM-JMDB)
no indication
MYLAN GMBH
